Study to Assess Long-term Effectiveness of Zomacton® and Treatment Adherence in Patients With Growth Hormone Deficiency or Ullrich-Turner Syndrome

NCT03274973 · clinicaltrials.gov ↗

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Insufficient, delayed recruitment of participants

Conditions

Growth Disorders

Interventions

DRUG: Zomacton

Sponsor

Ferring Pharmaceuticals